Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases
The classification and diagnosis of systemic autoimmune diseases are frequently based on a collection of criteria composed of clinical, laboratory, imaging, and pathology elements that are strongly associated with the respective disease. Autoantibodies are a distinctive hallmark and have a prominent...
Main Authors: | Luis Eduardo C. Andrade, Jan Damoiseaux, Diego Vergani, Marvin J. Fritzler |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Journal of Translational Autoimmunity |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909022000065 |
Similar Items
-
Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease
by: Irina A. Pashnina, et al.
Published: (2021-02-01) -
Antinuclear antibody-negative systemic lupus erythematosus
by: Krithiga Muralidharan, et al.
Published: (2023-01-01) -
Anti-Nuclear antibodies: Current concepts and future direction for diagnosing connective tissue disease
by: K Gautam
Published: (2015-03-01) -
Emerging technologies in autoantibody testing for rheumatic diseases
by: Nancy J. Olsen, et al.
Published: (2017-07-01) -
A case of acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis
by: Ferhat Demir, et al.
Published: (2019-06-01)